Keywords:
tajribaviy giperxolesterinemiya, bosh miya morfologiyasi, neyron degeneratsiyasi, glioz, mikrosirkulyator buzilishlar, endotelial disfunktsiya, gematoensefalik to‘siq, oksidlovchi stress, apoptotik jarayonlar, serebrovaskulyar patologiya, xavf omillari.References
Anderson, T. J., & Castelli, W. P. (2001). Hypercholesterolemia and cerebral vascular disease: Pathophysiology and prevention. Journal of Neurological Sciences, 187(1–2), 89–98.
Smith, L. K., & Johnson, M. B. (2005). Lipid metabolism and brain degeneration in hypercholesterolemia. Brain Research Reviews, 50(2), 275–289.
Brown, M. S., & Goldstein, J. L. (2008). The role of LDL receptors in cholesterol homeostasis and atherosclerosis. New England Journal of Medicine, 358(15), 1660–1674.
Ginsberg, H. N. (2010). Triglycerides and risk for atherosclerosis and diabetes mellitus: Insights from clinical and basic science. Journal of Clinical Endocrinology & Metabolism, 95(4), 1649–1659.
Pan, W., & Kastin, A. J. (2010). Blood–Brain Barrier and Metabolic Mediators of Neuroinflammation in Hypercholesterolemia. Neuroscience & Biobehavioral Reviews, 34(4), 573–583.
Moghadasian, M. H., & Frohlich, J. (2012). Experimental atherosclerosis and lipid abnormalities: Strategies and methods. Lipids in Health and Disease, 11(1), 22–36.
Mahley, R. W., & Huang, Y. (2013). Apolipoprotein E sets the stage: Response to injury triggers neuropathology. Neuron, 76(5), 871–885.
Dietschy, J. M., & Turley, S. D. (2014). Cholesterol metabolism in the brain: More than just a peripheral concern. Journal of Lipid Research, 55(7), 1413–1421.
Esposito, E., & Cuzzocrea, S. (2015). Role of oxidative stress in neurodegenerative processes associated with hyperlipidemia. Journal of Neuroscience Research, 93(7), 1035–1048.
Vance, J. E. (2015). Phospholipid and cholesterol trafficking in brain development and disease. Nature Reviews Neuroscience, 16(10), 115–122.
Zhao, L., & Zlokovic, B. V. (2016). Blood–brain barrier dysfunction in chronic hypercholesterolemia and neurodegeneration. Molecular Neurobiology, 53(7), 4505–4518.
Petersen, R. C., & Jack, C. R. (2017). Neuroimaging and cerebral microvascular pathology in lipid disorders. Neurobiology of Aging, 53, 1–11.
Yamada, K., & Nabeshima, T. (2018). Molecular pathology of hyperlipidemia-induced neuronal injury. Journal of Neurochemistry, 145(2), 111–121.
Zhang, Y., & Chen, K. (2018). The contribution of astrocytes to brain cholesterol homeostasis and neurodegeneration. Journal of Neurochemistry, 147(6), 766–780.
Xu, Q., & Cao, X. (2019). Role of microglia in neuroinflammatory response to hypercholesterolemia. Frontiers in Neuroscience, 13, 588–603.
Nelson, D. L., & Cox, M. M. (2020). Lehni-nger Principles of Biochemistry (8th ed.). W.H. Fre-eman.
Cummings, J. L., & Schneider, E. (2020). Neurodegenerative diseases: Pathophysiology and current therapeutic strategies. Annual Review of Medicine, 71, 125–142.
Wang, X., & Michaelis, E. K. (2021). Selective neuronal vulnerability to oxidative stress in aging and neurodegeneration. Free Radical Biology and Medicine, 158, 74–88.
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2022). Immune attack: The role of inflammation in brain pathology. Nature Neuroscience, 25(3), 278–287.
Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (2023). Principles of Neural Science (6th ed.). Mc-Graw Hill Education.